Tags

Type your tag names separated by a space and hit enter

Dyslipidemias in patients who have chronic kidney disease.
Med Clin North Am. 2005 May; 89(3):689-99.MC

Abstract

Patients with CKD are at high risk for developing CVD. In fact, most CKD patients have a 10-year risk of coronary heart disease events greater than or equal to 20%, placing them in the highest risk category according to the National Cholesterol Education Program Adult Treatment Panel III guidelines. For this reason, the National Kidney Foundation K/DOQI guidelines for managing dyslipidemia suggest that CKD patients with LDL greater than or equal to 100 mg/dL (2.59 mmol/L) should be treated with diet and a statin. The K/DOQI guidelines also make it clear that the evidence supporting treatment in CKD populations is lacking however, and that additional placebo-controlled trials are needed. In the mean time, the high incidence of CVD makes intensive monitoring and treatment of dyslipidemias in patients with CKD a reasonable clinical approach.

Authors+Show Affiliations

University of Minnesota, Minneapolis, MN 55415, USA. farba002@umn.eduNo affiliation info available

Pub Type(s)

Journal Article
Review

Language

eng

PubMed ID

15755473

Citation

Farbakhsh, Kambiz, and Bertram L. Kasiske. "Dyslipidemias in Patients Who Have Chronic Kidney Disease." The Medical Clinics of North America, vol. 89, no. 3, 2005, pp. 689-99.
Farbakhsh K, Kasiske BL. Dyslipidemias in patients who have chronic kidney disease. Med Clin North Am. 2005;89(3):689-99.
Farbakhsh, K., & Kasiske, B. L. (2005). Dyslipidemias in patients who have chronic kidney disease. The Medical Clinics of North America, 89(3), 689-99.
Farbakhsh K, Kasiske BL. Dyslipidemias in Patients Who Have Chronic Kidney Disease. Med Clin North Am. 2005;89(3):689-99. PubMed PMID: 15755473.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Dyslipidemias in patients who have chronic kidney disease. AU - Farbakhsh,Kambiz, AU - Kasiske,Bertram L, PY - 2005/3/10/pubmed PY - 2005/6/17/medline PY - 2005/3/10/entrez SP - 689 EP - 99 JF - The Medical clinics of North America JO - Med Clin North Am VL - 89 IS - 3 N2 - Patients with CKD are at high risk for developing CVD. In fact, most CKD patients have a 10-year risk of coronary heart disease events greater than or equal to 20%, placing them in the highest risk category according to the National Cholesterol Education Program Adult Treatment Panel III guidelines. For this reason, the National Kidney Foundation K/DOQI guidelines for managing dyslipidemia suggest that CKD patients with LDL greater than or equal to 100 mg/dL (2.59 mmol/L) should be treated with diet and a statin. The K/DOQI guidelines also make it clear that the evidence supporting treatment in CKD populations is lacking however, and that additional placebo-controlled trials are needed. In the mean time, the high incidence of CVD makes intensive monitoring and treatment of dyslipidemias in patients with CKD a reasonable clinical approach. SN - 0025-7125 UR - https://www.unboundmedicine.com/medline/citation/15755473/Dyslipidemias_in_patients_who_have_chronic_kidney_disease_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S0025-7125(04)00178-6 DB - PRIME DP - Unbound Medicine ER -